Results 211 to 220 of about 51,164 (271)

Analysis of positive and negative allosteric modulation in metabotropic glutamate receptors 4 and 5 with a dual ligand [PDF]

, 2017
James A. R. Dalton, Jean‐Philippe Pin, Jesús Giraldo   +2 more
openalex   +1 more source

Test–retest reproducibility of the metabotropic glutamate receptor 5 ligand [18F]FPEB with bolus plus constant infusion in humans

European Journal of Nuclear Medicine and Molecular Imaging, 2015
E. Park, Jenna M. Sullivan, B. Planeta, J. Gallezot, Keunpoong Lim, Shu-Fei Lin, J. Ropchan, T. McCarthy, Yu-Shin Ding, E. Morris, W. Williams, Yiyun Huang, R. Carson   +12 more
semanticscholar   +1 more source

The metabotropic glutamate receptor 5 negative allosteric modulator fenobam: pharmacokinetics, side effects, and analgesic effects in healthy human subjects. [PDF]

Pain, 2020
Cavallone LF, Montana MC, Frey K, Kallogjeri D, Wages JM, Rodebaugh TL, Doshi T, Kharasch ED, Gereau RW.   +8 more
europepmc   +1 more source

Protein kinase A directly phosphorylates metabotropic glutamate receptor 5 to modulate its function

Journal of Neurochemistry, 2015
K. Uematsu, M. Heiman, M. Zelenina, J. Padovan, B. Chait, A. Aperia, A. Nishi, P. Greengard   +7 more
semanticscholar   +1 more source

Involvement of serotonergic system in the effect of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test

, 2014
Kenichi Fukumoto, Shigeyuki Chaki
openalex   +1 more source

Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans

Molecular Psychiatry, 2014
L. Hulka, V. Treyer, M. Scheidegger, K. Preller, M. Vonmoos, Matthias R. Baumgartner, A. Johayem, S. Ametamey, S. Ametamey, Alfred Buck, Erich Seifritz, Boris B. Quednow   +11 more
semanticscholar   +1 more source

Metabotropic glutamate receptor 5 signaling and appetitive Pavlovian behavior: implications for the treatment of addiction. [PDF]

Neuropsychopharmacology, 2019
Richard JM.
europepmc   +1 more source

Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology. [PDF]

Neuropharmacology, 2019
Sengmany K, Hellyer SD, Albold S, Wang T, Conn PJ, May LT, Christopoulos A, Leach K, Gregory KJ.   +8 more
europepmc   +1 more source

Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation

, 2017
Andrew S. Felts, Alice L. Rodriguez, Anna L. Blobaum, Ryan D. Morrison, Brittney S. Bates, Analisa Thompson Gray, Jerri M. Rook, Mohammed Noor Tantawy, Frank W. Byers, Sichen Chang, Daryl F. Venable, Vincent B. Luscombe, Gilles Tamagnan, Colleen M. Niswender, J. Scott Daniels, Carrie K. Jones, P. Jeffrey Conn, Craig W. Lindsley, Kyle A. Emmitte   +18 more
openalex   +1 more source